Robert G. Shawah - 24 Jun 2021 Form 3 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Chief Financial Officer
Signature
/s/ Robert G. Shawah
Issuer symbol
ACXP
Transactions as of
24 Jun 2021
Transactions value $
$0
Form type
3
Filing time
24 Jun 2021, 18:22:34 UTC
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACXP Common Stock 189,200 24 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACXP Warrants for Common Stock 24 Jun 2021 Common Stock 625 $4 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney